Structural fresh-frozen allograft reconstruction of segmental defects after wide resection | advanced
Surgical Imaging
The trap: Treating the host-graft junction like a standard fracture — the allograft is avascular and provides no living cells or growth factors; union depends entirely on creeping substitution from the host.
The fix: Achieve absolute stability with compression plating or IM nailing spanning at least two cortical diameters on each side. Impact fresh autograft (iliac crest or reamings) circumferentially at both junctions. Avoid gaps greater than 1 mm. Chemotherapy and radiation delay union — plan for longer protected weight-bearing.
Location: Stress risers at screw holes, the junction itself, or within the graft diaphysis where vascular ingrowth is incomplete.
Risk: 5-15 percent incidence; higher with osteoarticular allografts and when adjuvant radiation is used. The graft never fully remodels to living bone — it remains a structural scaffold prone to fatigue failure.
Prevention: Use the largest diameter IM nail possible or multiple plates in different planes. Avoid unnecessary screw holes. Protect the reconstruction until radiographic union (minimum 6 months, often 12-18 months).
Why different: The allograft is a large avascular foreign body. Deep infection rates (5-15 percent) exceed those of megaprosthesis. Once infected, eradication usually requires graft removal, prolonged antibiotics and staged reconstruction.
Prevention: Strict aseptic technique, laminar-flow theatre, perioperative antibiotics for 24-48 hours (or longer if chemotherapy-induced neutropenia), meticulous soft-tissue coverage and muscle flaps when needed. Any post-operative wound issue must be treated aggressively.
The principle: One of the main advantages of allograft over megaprosthesis is the ability to reattach host tendons and ligaments directly to the graft (patellar tendon, rotator cuff, hip abductors).
Technique: Use heavy non-absorbable sutures through drill holes in the graft or through the preserved soft-tissue envelope on the allograft. For osteoarticular grafts, reconstruct the joint capsule and ligaments as in a revision arthroplasty.
Failure mode: Poor reattachment leads to instability, subluxation or dislocation — particularly devastating in proximal humerus or proximal tibia reconstructions.
Risk: Viral transmission (HIV, hepatitis) is now less than 1 in 1 million with modern screening, but bacterial contamination during procurement or processing remains a concern.
Selection: Use only grafts from accredited tissue banks with negative cultures, serology and irradiation (where indicated). Size matching is critical — a graft more than 2 mm smaller in diameter than the host canal leads to poor fit and fixation failure.
Storage: Fresh-frozen at minus 80 degrees Celsius is standard; never use freeze-dried grafts for structural applications because of reduced mechanical strength.
The trap: Offering allograft to every young patient without considering the higher early complication rate and slower rehabilitation.
The reality: Allograft offers superior long-term bone stock and biologic attachment but at the cost of 20-40 percent major complication rate in the first two years. Megaprosthesis provides immediate stability and faster return to function but sacrifices future revision options.
Decision factors: Patient age, defect location (diaphyseal favours intercalary allograft), need for tendon attachment, anticipated adjuvant therapy, and patient tolerance for prolonged protected weight-bearing.
G.R.A.F.TGRAFT — Structural Allograft Principles
U.N.I.O.NUNION — Monitoring and Managing Host-Graft Junctions
I.N.F.E.C.TINFECT — Prevention and Management of Allograft Infection
Surgical Indications
Absolute Indications
- Diaphyseal or intercalary segmental defect after wide resection of bone sarcoma (osteosarcoma, Ewing sarcoma, chondrosarcoma) in a patient younger than 40-50 years who desires biologic reconstruction and restoration of bone stock
- Osteoarticular defect requiring joint surface and ligament reconstruction (proximal tibia, distal femur, proximal humerus) when the patient is young and high-demand
- Need for tendon or ligament attachment sites that cannot be achieved with a megaprosthesis (patellar tendon, hip abductors, rotator cuff)
- Patient preference for allograft after informed discussion of risks versus endoprosthetic reconstruction
Relative Indications
- Allograft-prosthesis composite (APC) when the joint surface is not reconstructible with osteoarticular allograft but soft-tissue attachment is still desired
- Revision of failed megaprosthesis where bone stock restoration is required for future longevity
- Aggressive benign tumours (giant cell tumour, chondroblastoma) with massive bone loss after curettage and resection
Contraindications
Absolute:
- Active infection at the resection site
- Inability to achieve wide surgical margins
- Patient non-compliance with prolonged protected weight-bearing (minimum 6 months)
- Severe immunocompromise or uncontrolled diabetes with high infection risk
Relative:
- Age greater than 60-65 years (megaprosthesis usually preferred for faster rehabilitation)
- Requirement for post-operative radiation (increases nonunion and fracture risk)
- Smoking or poor soft-tissue envelope that cannot be optimised
Evidence for Allograft Reconstruction
Structural Allograft Outcomes
- Fresh-frozen structural allografts achieve union in 60-80 percent of host-graft junctions when rigid fixation and autograft augmentation are used
- Osteoarticular allografts have higher complication rates (fracture, joint degeneration) than intercalary grafts but preserve the option for biologic joint reconstruction in young patients
- Allograft-prosthesis composites combine the advantages of both techniques and are particularly useful in the proximal tibia where patellar tendon reattachment is critical
Comparison with Megaprosthesis
- Megaprosthesis provides immediate stability and faster return to weight-bearing (6-12 weeks) but sacrifices bone stock and future revision options
- Allograft reconstruction offers superior long-term bone stock and the possibility of tendon/ligament attachment but requires 6-18 months of protected weight-bearing and carries a 20-40 percent major complication rate in the first two years
- In patients younger than 40 years with diaphyseal defects, many centres favour allograft or allograft-prosthesis composite when the soft-tissue envelope allows
Key Evidence
Long-term results of allograft reconstruction after resection of bone tumours
Allograft-prosthesis composite reconstruction of the proximal tibia after tumour resection
Allograft reconstruction of intercalary defects after bone tumour resection
Observations on massive retrieved human allografts
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 28-year-old man undergoes wide resection of a distal femoral osteosarcoma with a 12 cm intercalary defect. He has completed neoadjuvant chemotherapy and is eager to return to construction work. Discuss your choice of reconstruction and the key technical points.”
“A 35-year-old woman with a proximal tibial giant cell tumour has undergone wide resection with sacrifice of the patellar tendon insertion. She desires reconstruction that maximises her chance of returning to recreational running. Compare allograft-prosthesis composite versus megaprosthesis.”
“A 42-year-old man with a distal femoral osteosarcoma treated with neoadjuvant chemotherapy and wide resection with intercalary allograft reconstruction now presents at 16 months with persistent pain on weight-bearing. Radiographs show no bridging callus at the proximal host-graft junction and a 2 mm gap. How do you approach this?”